# A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

> **NCT00259805** · PHASE1 · COMPLETED · sponsor: **California Pacific Medical Center Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Chronic Focal Encephalitis
- Rasmussen's Encephalitis

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00259805
- **Lead sponsor:** California Pacific Medical Center Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259805, "A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00259805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*